fenofibrate
Showing 1 - 25 of 84
Safety Study of Fenofibrate During Pregnancy
Recruiting
- Severe Hypertriglyceridemia During Pregnancy
- Fenofibrate
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
May 31, 2023
Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)
Not yet recruiting
- Breast Cancer Stage 2 and 3
- Fenofibrate
- +3 more
- (no location specified)
Nov 24, 2023
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes
Recruiting
- Covid19
- Fenofibrate
- Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 18, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 11, 2023
Liver Transplant Trial in Phoenix (Fenofibrate)
Recruiting
- Liver Transplant
- Fenofibrate
-
Phoenix, ArizonaMayo Clinic Arizona
Aug 23, 2022
Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)
Recruiting
- Diabetic Nephropathies
- Fenofibrate
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 15, 2022
Diabetes, Type II Trial in Charleston (Fenofibrate)
Completed
- Diabetes Mellitus, Type II
- Fenofibrate
-
Charleston, South CarolinaMedical University of South Carolina
Jan 11, 2022
Primary Biliary Cirrhosis Trial in Beijing (Fenofibrate, UDCA)
Withdrawn
- Primary Biliary Cirrhosis
- Fenofibrate
- UDCA
-
Beijing, ChinaBeijing 302 hospital
Sep 12, 2021
Diabetic Retinopathy, Dyslipidemias, Diabetes Trial (Fenofibrate, Placebo)
Completed
- Diabetic Retinopathy
- +2 more
- Fenofibrate
- Placebo
- (no location specified)
May 9, 2021
Huntington Disease Trial in Irvine (Fenofibrate, Placebo)
Active, not recruiting
- Huntington Disease
- Fenofibrate
- Placebo
-
Irvine, CaliforniaUniversity of California, Irvine
Apr 15, 2021
Diabetes, Diabetic Nephropathies Trial in Singapore (Fenofibrate)
Recruiting
- Diabetes Mellitus
- Diabetic Nephropathies
- Fenofibrate
-
Singapore, SingaporeSingapore General Hospital
Dec 10, 2020
Nonalcoholic Steatohepatitis (NASH) Trial in United States (Firsocostat, Fenofibrate)
Completed
- Nonalcoholic Steatohepatitis (NASH)
- Firsocostat
- Fenofibrate
-
Tustin, California
- +4 more
Nov 23, 2020
Neonatal Jaundice Trial (Fenofibrate, Placebo)
Completed
- Neonatal Jaundice
- Fenofibrate
- Placebo
- (no location specified)
Jun 2, 2020
HIV, Lipodystrophy Trial in Puerto Rico, United States (Pravastatin sodium, Fenofibrate)
Completed
- HIV Infections
- Lipodystrophy
- Pravastatin sodium
- Fenofibrate
-
Birmingham, Alabama
- +57 more
Oct 28, 2021
Non Familial Chylocmicronemia Syndrome (Non-FCS) Trial in Canada, Russian Federation, United States (LCQ908, Fenofibrate, Fish
Completed
- Non Familial Chylocmicronemia Syndrome (Non-FCS)
- LCQ908
- +5 more
-
Muscle Shoals, Alabama
- +31 more
Dec 11, 2020
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
Completed
- Dyslipidemia
- fenofibrate
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 9, 2020
Dyslipidemia Trial in Chicago (LCP-AtorFen, atorvastatin, fenofibrate)
Completed
- Dyslipidemia
- LCP-AtorFen
- +2 more
-
Chicago, IllinoisRadiant Research, 515 N State Street, Suite 2700
Feb 4, 2020
Burn Trial in Galveston (Fenofibrate, Placebo, Propranolol)
Terminated
- Burn
- Fenofibrate
- +2 more
-
Galveston, TexasShriners Hospitals for Children
Nov 26, 2019
Second or Third Degree Burns Trial in Galveston (Fenofibrate, Sugar Pill)
Terminated
- Second or Third Degree Burns
- Fenofibrate
- Sugar Pill
-
Galveston, TexasUniversity of Texas Medical Branch
Nov 26, 2019
HIV, Fenofibrate, Protease Inhibitors Trial run by the CC (Fenofibrate, Ritonavir, Lopinavir/Ritonavir)
Completed
- HIV
- +4 more
- Fenofibrate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 6, 2019
Hypercholesterolemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin)
Completed
- Hypercholesterolemia
- Alirocumab SAR236553 (REGN727)
- +11 more
-
Sao Paulo, Brazil
- +9 more
Dec 2, 2020
Atherogenic Dyslipidemia, Obesity Associated Disorder Trial in Baghdad (other, drug, dietary supplement)
Completed
- Atherogenic Dyslipidemia
- Obesity Associated Disorder
- Therapeutic Lifestyle Changes
- +3 more
-
Baghdad, Iraq
- +1 more
Sep 2, 2019
Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))
Spinal Cord Injury, Dyslipidemia Trial in West Orange, Bronx (Fenofibrate, No intervention)
Completed
- Spinal Cord Injury
- Dyslipidemia
- Fenofibrate
- No intervention
-
West Orange, New Jersey
- +1 more
Jun 7, 2019